Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment by François R. Girardin, Karen Cohen, Matthias Schwenkglenks, Matthias Schwenkglenks, Isabelle Durand-Zaleski

Get full text

How to evaluate health-related quality of life and its association with medication adherence in pulmonary tuberculosis – designing a prospective observational study in South Africa... by Tanja Kastien-Hilka, Tanja Kastien-Hilka, Tanja Kastien-Hilka, Bernd Rosenkranz, Bernd Rosenkranz, Bryan Bennett, Edina Sinanovic, Matthias Schwenkglenks, Matthias Schwenkglenks, Matthias Schwenkglenks

Get full text

Association between Health-Related Quality of Life and Medication Adherence in Pulmonary Tuberculosis in South Africa by Tanja Kastien-Hilka, Tanja Kastien-Hilka, Tanja Kastien-Hilka, Bernd Rosenkranz, Bernd Rosenkranz, Matthias Schwenkglenks, Matthias Schwenkglenks, Matthias Schwenkglenks, Bryan M. Bennett, Edina Sinanovic

Get full text

Handling Uncertainty in Cost-Effectiveness Analysis: Budget Impact and Risk Aversion by Pedram Sendi, Klazien Matter-Walstra, Matthias Schwenkglenks

Get full text

General Practitioners’ Awareness and Perception of Current Pneumococcal Vaccination for Adult Patients with Known Risk Factors in Switzerland: Evidence from a Survey by Sandro Tiziano Stoffel, Matthias Schwenkglenks, Thomas Mutschler

Get full text

Impact of Body Mass Index on mortality in Swiss hospital patients with ST-elevation myocardial infarction: does an obesity paradox exist? by Fabienne Witassek, Matthias Schwenkglenks, Paul Erne, Dragana Radovanovic

Get full text

Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland by Arjun Bhadhuri, Ralph Insinga, Patrik Guggisberg, Cedric Panje, Matthias Schwenkglenks

Get full text

Health-related quality of life in South African patients with pulmonary tuberculosis. by Tanja Kastien-Hilka, Bernd Rosenkranz, Edina Sinanovic, Bryan Bennett, Matthias Schwenkglenks

Get full text

Herpes zoster vaccine: A health economic evaluation for Switzerland by Patricia R. Blank, Zanfina Ademi, Xiaoyan Lu, Thomas D. Szucs, Matthias Schwenkglenks

Get full text

Systematic early versus late mobilization or standard early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis by Dominik Menges, Bianca Seiler, Yuki Tomonaga, Matthias Schwenkglenks, Milo A. Puhan, Henock G. Yebyo

Get full text

Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction by Zanfina Ademi, Alena M Pfeil, Elizabeth Hancock, David Trueman, Rola Haroun, Céline Deschaseaux, Matthias Schwenkglenks

Get full text

Productivity losses due to influenza and influenza-like illness in Switzerland: results of the Swiss Sentinel Surveillance Network in a non-pandemic era by Yuki Tomonaga, Kyra Denise Zens, Phung Lang, Rita Born, Matthias Schwenkglenks, and the Swiss Sentinel Surveillance Network

Get full text

Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland by Arjun Bhadhuri, Daniel Dröschel, Mike Guldimann, Claudia Jetschgo, Judit Banhazi, Matthias Schwenkglenks, C. Simone Sutherland

Get full text

Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspect... by Zanfina Ademi, Viktoria Gloy, Dominik Glinz, Heike Raatz, Joris Van Stiphout, Heiner C Bucher, Matthias Schwenkglenks

Get full text

Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland by Verena Jürgens, Silvia Ess, Harish C. Phuleria, Martin Früh, Matthias Schwenkglenks, Harald Frick, Thomas Cerny, Penelope Vounatsou

Get full text

Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data by Rahel Schneider, Daphne Reinau, Nadine Schur, Eva Blozik, Mathias Früh, Andri Signorell, Christoph R. Meier, Matthias Schwenkglenks

Get full text

Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013–2019 by Daphne Reinau , Nadine Schur, Sibylle Twerenbold , Eva Blozik , Mathias Früh, Andri Signorell, Matthias Schwenkglenks , Christoph R. Meier

Get full text

Tobacco-related cancer mortality: projections for different geographical regions in Switzerland by Verena Jürgens, Silvia Ess, Harish C. Phuleria, Martin Früh, Matthias Schwenkglenks, Harald Frick, Thomas Cerny, Penelope Vounatsou

Get full text

Determining the Relationship Between Seizure-Free Days and Other Predictors of Quality of Life in Patients with Dravet Syndrome and Their Carers from FFA Registration Studies by Amy Pinsent, Georgie Weston, Elisabeth J. Adams, Warren Linley, Neil Hawkins, Matthias Schwenkglenks, Charlotte Hamlyn-Williams, Toby Toward

Get full text

Early mobilisation and rehabilitation in Swiss intensive care units: a cross-sectional survey by Yuki Tomonaga, Dominik Menges, Henock G. Yebyo, Thierry Fumeaux, Antje Heise, Conrad Wesch, Matthias Schwenkglenks, Milo A. Puhan

Get full text